CAPLYTA’S Strong Market Adoption Propels Its Rise As A Leading Antipsychotic Therapy | Delveinsight
Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...
Synthesis method unlocks a pathway to valuable fluorinated drug compounds for new medicines
Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts ...
Cathie Wood Explains Why She Likes Recursion Pharmaceuticals, Inc. (RXRX)
We recently published a list of the Top 10 AI Stocks Buzzing on Latest News. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against the ...
ARS Pharmaceuticals says OptumRx, Cigna, Navitus add neffy to formularies
ARS Pharmaceuticals (SPRY) announced that Cigna Healthcare, Navitus Health Systems and OptumRx, through their Group ...
The National Law Review2d
China on the Move: Lessons from China’s 2024 National Negotiation of Drug Prices
China’s share of the global drug development pipeline grew from 3% in 2013 to 28% in 2023, positioning China as the ...
Psychedelic: Exclusive talk with biotech company Enveric Biosciences
In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...
Radiopharmaceutical Industry Trends Shaping 2025
The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...